MLAB
MESA LABORATORIES INC /CO/
$105.68
+1.62%
$574.6M
No data for this timeframe.
Vol
Market Cap$574.6M
Cap SizeSmall Cap
Inst. Holders8 funds
Inst. Value$50.0M
Inst. Activity2 buys / 2 sells
Insider Activity3B / 0S
Insider Net $$452.1K
SEC Reports1
Press Releases2
Exchange Nasdaq·Sector Industrial Instruments For Measurement, Display, and Control·Inc. CO·CIK 0000724004·Prev Close $104.00
Recent Activity
May 27, 2026
earnings_calendar
MLAB Q4 2026 Earnings Before Market Open — 2026-05-27
May 5, 2026
Press
Mesa Laboratories announced it will release financial results for Q4 and fiscal year ended March 31, 2026, on May 27, 20
Impact 2/10
Apr 14, 2026
Insider
Kadia Siddhartha sold 35,236 shares
President and CEO @ $0.00 ($0.00)
Apr 14, 2026
Insider
Kadia Siddhartha sold 34,807 shares
President and CEO @ $0.00 ($0.00)
Mar 31, 2026
Insider
Owens Gary M sold 8,211 shares
President and CEO @ $0.00 ($0.00)
Mar 10, 2026
SEC
Two independent directors at Mesa Laboratories (MLAB) made nearly identical open-market purchases of approximately $99,3
CLUSTER — Impact 7/10
Inst.
MORGAN STANLEY — TRIM
175,589 shares ($13.8M)
Inst.
TWO SIGMA INVESTMENTS, LP — ADD
12,235 shares ($960.4K)
Price Targets
Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$104.50 (Feb 2026)
Current $105.68
Low $94.00
Median $104.50
High $115.00
2 analysts
$94.00
$115.00
Analyst Ratings
3Strong Buy
3Buy
3Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Feb 4, 2026 | Wells Fargo | MAINTAIN | Equal-Weight → Equal-Weight |
| Dec 15, 2025 | Wells Fargo | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.39 ▼ -6.1% | $1.39 — $1.39 | 226% YoY | 1 |
| Next Q | $1.06 ▼ -31.6% | $1.06 — $1.06 | -44% YoY | 1 |
| Current FY | $7.35 ▲ +2.9% | $7.35 — $7.35 | 21% YoY | 1 |
| Next FY | $5.39 ▼ -11.1% | $5.39 — $5.39 | -27% YoY | 1 |
Latest Reports
NEUTRAL
Press
2/10
Mesa Laboratories announced it will release financial results for Q4 and fiscal year ended March 31, 2026, on May 27, 20
May 5, 2026
BULLISH
CLUSTER
7/10
Two independent directors at Mesa Laboratories (MLAB) made nearly identical open-market purchases of approximately $99,3
Mar 10, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $25.3M | — |
| MORGAN STANLEY | $13.8M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $4.9M | NEW |
| BANK OF AMERICA CORP | $4.3M | TRIM |
| TWO SIGMA INVESTMENTS, LP | $960.4K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 14, 2026 | Kadia Siddhartha | A | $0.00 |
| Apr 14, 2026 | Kadia Siddhartha | A | $0.00 |
| Mar 31, 2026 | Owens Gary | D | $0.00 |
| Mar 10, 2026 | Ladiwala Shiraz | BUY | $252.8K |
| Mar 10, 2026 | Tripeny R | BUY | $99.9K |
8 institutional holders with $50.0M total value (636,398 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 321,899 | $25.3M | 50.6% | — |
| 2 | MORGAN STANLEY | 175,589 | $13.8M | 27.6% | TRIM -31.1% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 61,913 | $4.9M | 9.7% | NEW |
| 4 | BANK OF AMERICA CORP /DE/ | 54,664 | $4.3M | 8.6% | TRIM -27.5% |
| 5 | TWO SIGMA INVESTMENTS, LP | 12,235 | $960.4K | 1.9% | ADD +27.1% |
| 6 | WELLS FARGO & COMPANY/MN | 5,752 | $451.6K | 0.9% | TRIM -71.5% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 3,500 | $274.8K | 0.5% | TRIM -67.9% |
| 8 | FMR LLC | 846 | $66.4K | 0.1% | ADD +39.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 254,974 | 175,589 | -31.1% | $13.8M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 9,623 | 12,235 | +27.1% | $960.4K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 10,900 | 3,500 | -67.9% | $274.8K | 2025-Q4 |
| FMR LLC | ADD | 606 | 846 | +39.6% | $66.4K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 64,928 | 47,099 | -27.5% | $3.2M | 2025-Q3 |
| UBS Group AG | TRIM | 31,294 | 19,161 | -38.8% | $1.3M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 68,027 | 10,900 | -84.0% | $730.4K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 9,623 | — | $644.8K | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | TRIM | 18,143 | 5,176 | -71.5% | $346.8K | 2025-Q3 |
| FMR LLC | NEAR_EXIT | 2,923 | 606 | -79.3% | $40.6K | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 8,200 | 68,027 | +729.6% | $6.4M | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | TRIM | 30,019 | 18,143 | -39.6% | $1.7M | 2025-Q2 |
| UBS Group AG | ADD | 19,752 | 27,387 | +38.7% | $3.2M | 2025-Q1 |
| FMR LLC | DOUBLED | 1,377 | 2,897 | +110.4% | $343.8K | 2025-Q1 |
| UBS Group AG | DOUBLED | 5,792 | 19,752 | +241.0% | $2.6M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 13,400 | 7,500 | -44.0% | $989.0K | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 10,715 | 6,817 | -36.4% | $899.0K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 62,609 | — | $8.1M | 2024-Q3 |
5 unique insiders with 3 transactions. Net insider value: $452.1K ($452.1K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | Kadia Siddhartha | President and CEO | A | 35,236 | $0.00 | $0.00 |
| Apr 14, 2026 | Kadia Siddhartha | President and CEO | A | 34,807 | $0.00 | $0.00 |
| Mar 31, 2026 | Owens Gary M | President and CEO | D | 8,211 | $0.00 | $0.00 |
| Mar 10, 2026 | Ladiwala Shiraz Shabanali | Director | BUY | 3,500 | $72.23 | $252.8K |
| Mar 10, 2026 | Tripeny R Tony | Director | BUY | 1,315 | $76.00 | $99.9K |
| Mar 10, 2026 | Capone Mark Christopher | Director | BUY | 1,301 | $76.35 | $99.3K |
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
Historical analyst distribution (last covering-analyst action Feb 2026): 67% buy across 9 analysts — 3 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$104.50 mean target (Feb 2026)
$94.00 Low
$115.00 High
| Metric | Value |
|---|---|
| Current Price | $105.68 |
| Target Low | $94.00 |
| Target Mean | $104.50 |
| Target Median | $104.50 |
| Target High | $115.00 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$1.39 | $1.39 | $1.39 | 226.0% | -6.1% | 0↑ 1↓ | $0.1B | 4.9% | 1 |
| Next Q 2026-06-30 |
$1.06 | $1.06 | $1.06 | -43.6% | -31.6% | 0↑ 1↓ | $0.1B | 4.6% | 1 |
| Current FY 2026-03-31 |
$7.35 | $7.35 | $7.35 | 20.6% | +2.9% | 1↑ 0↓ | $0.3B | 4.0% | 1 |
| Next FY 2027-03-31 |
$5.39 | $5.39 | $5.39 | -26.7% | -11.1% | 0↑ 1↓ | $0.3B | 5.0% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.390 | |
| 7d ago | $1.480 | -0.090 |
| 30d ago | $1.480 | -0.090 |
| 60d ago | $1.480 | -0.090 |
| 90d ago | $1.440 | -0.050 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Feb 4, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Dec 15, 2025 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Apr 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Mar 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Feb 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Jan 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 27, 2026
earnings_calendar
MLAB Q4 2026 Earnings Before Market Open — 2026-05-27
May 5, 2026
announcement
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
<p><strong>LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- </strong>Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financia
Apr 2, 2026
announcement
MESA LABS DECLARES QUARTERLY DIVIDEND
<p align="start"><b>LAKEWOOD, Colo., April 02, 2026 (GLOBE NEWSWIRE) -- </b>Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Compa
Mar 9, 2026
announcement
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
<p><b>LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) -- </b> Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa” or “the Company”), a global leader in